References
- Chapman K R, Ernst P, Grenville A, Dewland P, Zimmerman S. Control of asthma in Canada: failure to achieve guideline targets. Can Respir J 2001; 8(suppl A)35A–40A, [PUBMED], [INFOTRIEVE]
- Bender B, Milgrom H, Rand C S. Nonadherence in asthmatic patients: is there a solution to the problem?. Ann Allergy, Asthma, & Immun 1997; 79: 177–186
- Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47(6)555–567, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Apter A J, ZuWallack R L, Clive J. Common measures of asthma severity lack association for describing its clinical course. J Allergy Clin Immunol 1994; 94: 732–737, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yeung M, O'Connor S A, Parry D T, Cochrane G M. Compliance with prescribed drug therapy in asthma. Respir Med 1994; 88: 31–35, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rudd H P. In search of the gold standard of compliance measurement. Arch Intern Med 1977; 139: 627–628, [CROSSREF]
- Boulet L P, Becker A, Berube D, Beveridge R, Ernst P. Canadian asthma consensus report. Can Med Assoc J 1999; 161: S1–S5
- Saunders K, Simon G, Bush T, Grothaus L. Assessing the feasibility of using computerized pharmacy refill data to monitor antidepressant treatment on a population basis: a comparison of automated and self‐report data. J Clin Epidemiol 1998; 51(10)883–890, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sherman J, Hutson A, Baumstein S, Hendeles L. Telephoning the patient's pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptions. J Pediatr 2000; 136(4)532–536, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bender B, Wamboldt F S, O'Connor S L, Rand C, Szefler S, Milgrom H, Wamboldt M Z. Measurement of children's asthma medication adherence by self report, mother report, canister weight and doser CT. Ann Allergy, Asthma, & Immun 2000; 85(5)416–421
- Simmons M S, Nides N A, Kleerup E C, Chapman K R, Milgrom H, Rand C S, Spector S L, Tashkin D P. Validation of the doser, a new device for monitoring metered‐dose inhaler use. J Allergy Clin Immun 1998; 102(3)409–413, [PUBMED], [INFOTRIEVE]
- Simmons M S, Nides M A, Rand C S, Wise R A, Tashkin D P. Unpredictability of deception in compliance with physician‐prescribed bronchodilator inhaler use in a clinical trial. Chest 2000; 118(2)290–295, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chmelik F, Doughty A. Objective measurement of compliance in asthma treatment. Ann Allergy 1994; 73: 527–532, [PUBMED], [INFOTRIEVE]
- Braunstein G L, Trinquet G, Harper A E. Compliance with nedocromil sodium and a nedocromil sodium/salbutamol combination. Eur Respir J 1996; 9: 893–898, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Spector S L, Kinsman R, Mawhinney H, Siegel S C, Rachelefsky G S, Katz R M, Rohr A S. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol 1986; 77: 65–70, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rand C S, Wise R A. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994; 149: S69–S76, [PUBMED], [INFOTRIEVE]